Skip to content

Sio Capital Management, LLC 13F Holdings · Q2 2026

Sio Capital Management, LLC reported 57 securities worth $604.29M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: AVR (9.04%), COR (8.13%), MMS (6.36%). Among its top 25 positions this quarter: 9 new, 8 added, 7 trimmed.

RankTickerCompanyValue% PortfolioSharesAction
1AVRANTERIS TECHNOLOGIES GLOBAL$54.6M9.04%5.5MAdded
2CORCENCORA INC$49.1M8.13%173,588Added
3MMSMAXIMUS INC$38.5M6.36%715,267Trimmed
4ALLOALLOGENE THERAPEUTICS INC$27.7M4.59%13.3MNew
5GMEDGLOBUS MED INC$23.8M3.95%301,816New
6GSKGSK PLC$22.9M3.79%436,700Added
7TYRATYRA BIOSCIENCES INC$22.2M3.68%695,315Added
8WAYWAYSTAR HLDG CORP$19.0M3.15%925,834Trimmed
9SLSSELLAS LIFE SCIENCES GROUP I$18.2M3.01%1.2MNew
10IDYAIDEAYA BIOSCIENCES INC$17.9M2.96%480,383New
11ORKAORUKA THERAPEUTICS INC$16.9M2.79%177,118Added
12CITHE CIGNA GROUP$15.9M2.63%57,750New
13SNYSANOFI SA$15.5M2.57%364,200Added
14ICLRICON PUB LTD CO$15.3M2.53%88,186Trimmed
15VTRSVIATRIS INC$15.2M2.51%954,299New
16CCRNCROSS CTRY HEALTHCARE INC$14.5M2.40%1.1MHold
17RAPPRAPPORT THERAPEUTICS INC$12.8M2.12%307,657Trimmed
18ABTABBOTT LABORATORIES$11.7M1.93%128,656Trimmed
19CELCCELCUITY INC$11.5M1.90%110,022Trimmed
20ZBHZIMMER BIOMET HOLDINGS INC$11.3M1.87%131,445Added
21REGNREGENERON PHARMACEUTICALS$11.2M1.86%18,000New
22BMYBRISTOL-MYERS SQUIBB CO$11.1M1.85%193,500New
23MDTMEDTRONIC PLC$11.1M1.84%142,500New
24VIRVIR BIOTECHNOLOGY INC$11.0M1.81%1.1MTrimmed
25SENSSENSEONICS HLDGS INC$9.0M1.50%1.6MAdded

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR